CCL22 and neoplasm: TAMs‐released CCL22 activates intratumoral CCR4/FAK/AKT axis, which induces the phosphorylation of Gli1 Ser112/Thr115/Ser116 sites, and stimulates Gli1 activity to induce the stemness and metastasis of tumor cells.